Bone Growth Stimulator Market 2019 Segments, Trends, Share and Forecast Growth


The Global Bone Growth Stimulator Market is expected to reach $ 1.41 billion, at a CAGR of 5.4%

The growing patient preference for non-invasive and minimally invasive surgical treatments, increasing target patient population, and procedural benefits offered by bone stimulation devices in bone fracture treatments are some key factors propelling the growth of this Bone Growth Stimulator Market.

Bone growth Stimulator Market by devices offer a cost-effective and safer alternative mode to treat orthopedic diseases as compared to traditional surgical therapies for nonunion bone fractures. These devices have been reported to shorten the patient’s hospital stay as well as lessen the risks of complications and infections.

Download PDF (Bone Growth Stimulator):

Bone Growth Stimulator Market segmentation:

· based on products.

· based on application.

· based on end users.

· based on regions.

Speak to Our Subject Expert:

Hospitals and Clinics Form the Fastest Growing End-User Segment.


This segment includes both government and private hospitals that provide treatment or conduct surgeries related to spine, oral and maxillofacial, nonunion/delayed union fractures and dental practices. An increasing patient population, rising procedural volumes of spinal fusion surgeries, growing prevalence of spinal disorders, and growing awareness on bone growth stimulation products are aiding the growth of this segment.

The Major Players Operating in the Bone Growth Stimulator Market:

Orthofix International N.V. (U.S.), DJO Finance LLC (U.S.), Zimmer Biomet Holdings, Inc. (U.S.), Bioventus LLC (U.S.), Medtronic plc (Ireland), Stryker Corporation (U.S.), DePuy Synthes (U.S.), Arthrex, Inc. (U.S.), and Harvest Technologies Corporation (U.S.) are some of the key players in the bone growth stimulator market.

Request Research Sample Pages:

Geographical Detailed Analysis for Bone Growth Stimulator Market:

The bone growth stimulator market is classified into North America, Europe, Asia-Pacific, and the Rest of the World.

The global bone growth stimulator market was dominated by North America mainly due to the growing elderly population, increasing the incidence of arthritis and sports injuries, adoption of novel treatment options, and rising demand for minimally invasive spinal surgeries. rising awareness among healthcare professionals related to the novel and upcoming treatment options, and ongoing government initiatives to modernize & expand healthcare infrastructure.

The Asia-pacific market is expected to grow at the highest CAGR during the Forecast Period.


Please enter your comment!
Please enter your name here